Members are expected to attend all meetings of the Group and will contribute to the maintenance and further development of its portfolio of research by:

2. QUALITIES

Scientific members should have a track record of participation in research in the relevant Dementias & Neurodegenerative Diseases research strand.

Members should contribute actively to the work of their Group, and support studies within the Group portfolio. Membership may be terminated if a member fails to attend three consecutive meetings. Membership is in an individual capacity, and attendance of deputies for specific meetings should reflect exceptional circumstances and be by prior arrangement with the Group Chair.

The intention is to develop a portfolio that is well balanced and draws on local DeNDRoN strengths to stimulate accruals. The composition of each Group should reflect this and members should, therefore, be able to demonstrate some of the following: 

• Experience of collaborative clinical studies activity in a leadership capacity
• Success in trial accrual into national studies
• Evidence of publications and/or presentations nationally/internationally
• Links with Dementias & Neurodegenerative Diseases research networks
• Enthusiasm and commitment to developing Dementias & Neurodegenerative Diseases research

3. RELATIONSHIPS

Members will be responsible to the DeNDRoN OSG through the Group Chair. Secretariat support will be provided by the secretarial support provided by DeNDRoN to the Strand Associate Director, who will chair the relevant CSG for the first 3 years.


4. REMUNERATION

Work relating to the Groups is regarded as National Work for the purposes of the consultant contract and job planning. Membership of a Clinical Studies Group is unpaid. Reasonable travel expenses will be reimbursed in accordance with UKCRN and DeNDRoN finance policy.